# Ex Vivo Drug Response Profiling Reveals Two AML Subgroups with Distinct Kinase Activity, Immune Profiles and Gene Expression Linked to Clinical Survival Outcomes

## Overview![image](https://github.com/user-attachments/assets/5df78699-cc15-4992-b459-96ef3a507449)



